BSEM BioStem Technologies Inc.

OTC
$4.14

BioStem Technologies Inc. (BSEM) is expected to report earnings on November 16, 2026, after the market close. The consensus earnings estimate is a loss of $0.43 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +80.0% since its last earnings release on August 12, 2026.

BioStem Technologies Missed Consensus Estimates
Wednesday, August 12, 2026 · 4:05 PM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 16
Monday · 4:05 PM ET
Earnings Whisper
-
vs ($0.43)
Rev est $8M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $3.93

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About BioStem Technologies Inc.

ioStem Technologies is a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture and commercialization of allografts for regenerative therapies.

Sector

Healthcare

Industry

Biotechnology

Charts powered in part by Lightweight Charts™ by TradingView.